Bitcoin 4.66
$7,517.65 0.06203%
Ethereum 3.22
$150.68 2.13921%
XRP 0.00
$0.23 1.29473%
Zcash -0.27
$29.29 -0.90482%
Monero -0.32
$53.80 -0.59879%
Tether -0.00
$1.00 -0.15526%
Elite -0.00
$0.00 -9.63909%
Stellar 0.00
$0.06 0.55518%
Token sale completed on 30 November
Goal: 55,000,000 USD
Website Whitepaper

Biohal's mission try to create a universally available preventive medicine platform that runs on blockchain with liquid biopsy protocol. By joining hands with PROTEO, the very first liquid biopsy studies partner, Biohal can identify cancer and alzheimers at initial phases. With minimally invasive markers, Biohal's test accuracy continues to be at 99%.

Token Sale: 15 November — 30 November
Token type
ICO Token Price
Fundraising Goal
Total Tokens
Available for Token Sale
Know Your Customer
Сant participate
Hype rate
Risk rate
Team Value
Short review
Number of team Members
Team From
This website uses cookies and asks your personal data to enhance your browsing experience.